In a study published in Signal Transduction and Targeted Therapy, the researchers used MIR2911, a plant microRNA enriched in honeysuckle, as a proof-of-concept example.

Rain does more than water a garden. Every time a drop lands on a leaf, something quietly remarkable happens inside the plant.

Researchers at the University of Bayreuth and Forschungszentrum Jülich have demonstrated that specific light-sensitive ...

A research team led by Prof. Liu Qingsong at the Institute of Health and Medical Technology, the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has discovered a new drug ...

A signaling system known as the Wnt pathway plays a central role in how cells in the intestine grow, divide and renew themselves. Decades of research have shown that disruption of this pathway is a ...

To celebrate 100 years of American Heart Association-supported cardiovascular disease research, this review article highlights milestone papers that have significantly contributed to the current ...

After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Lizzy leads STAT’s coverage of the FDA. Her ...

Correspondence to Prof Chun Ming Wong; jackwong{at}pathology.hku.hk; Dr Carmen Chak-Lui Wong; carmencl{at}pathology.hku.hk Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, ...

NEW YORK, Nov 12 (Reuters) - The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic diseases based on data from a handful of patients, two of the ...